2004
DOI: 10.1200/jco.2004.22.14_suppl.6576
|View full text |Cite
|
Sign up to set email alerts
|

A novel platform for radioimmunotherapy. Extracorporeal depletion of biotinylated and 90Y-labeled anti-CD20 in patients with refractory B-cell lymphoma

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles